Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Risk of cardiovascular disease-related mortality in hematologic malignancy patients: A population-level US retrospective cohort study, 1975-2022

Husayn Ladha, Hetty Carraway, Aaron Gerds, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 4497.

https://doi.org/10.1182/blood-2025-4497

Published: 2025

Journal Articles

Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort

Blood (2025) 146 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2025-5185

Published: 2025

Journal Articles

Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis

Blood (2025) 146 (Supplement 1): 6712.

https://doi.org/10.1182/blood-2025-6712

Published: 2025

Journal Articles

Prognostic impact of mutations in the DNA methylation pathway on clinical outcomes in acute myeloid leukemia: A retrospective cohort study

Blood (2025) 146 (Supplement 1): 5254.

https://doi.org/10.1182/blood-2025-5254

Published: 2025

Journal Articles

Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates

Blood (2025) 146 (Supplement 1): 7035.

https://doi.org/10.1182/blood-2025-7035

Published: 2025

Journal Articles

The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission

Kai Yu, Laura Dillon, Jesse Tettero, Gege Gui, Rasha Al-Ali, Michael Grunwald, Elizabeth Krakow, Elizabeth Griffiths, Alexandra Gomez-Arteaga, Rahul Vedula, Melhem Solh, Amandeep Salhotra, Nelli Bejanyan, Lori Muffly, Antonio Jimenez-Jimenez, Michael Drazer, Yi-Bin Chen, Aaron Logan, Reena Jayani-Kosarzycki, Sophia Balderman, James Blachly, Brian Shaffer, Marc Schwartz, Cecilia Yeung, Lawrence Druhan, Vanessa Kennedy, Sandeep Gurbuxani, Melissa Tjota, Max Smith, Farah Sahoo, Dylan Barfield, Jim Guo, James Han, Jason Hu, Heejoon Jo, Vidya Kudlingar, Wilfred Li, Yutong Qiu, Pratheesh Sathyan, Sean Truong, Severine Catreux, Sam Ng, Khai Luong, Yunjiao Zhu, Reem Bahr, Jamie Diemer, Jianqun Kou, Stephanie Bo-Subait, Jackie Bjerke, Steven Devine, Bergetta Dietel, Christina Ferrone, Gabrielle Giammarino, Emily Heying, Emily Kolb, Danielle O'Donnell Vitali, Wael Saber, Stephen Spellman, Brenna Tesch, Jenny Vogel, Stephanie Waldvogel, Syreeta Weatherspoon, Jeffery Auletta, Christopher Hourigan

Blood (2025) 146 (Supplement 1): 455.

https://doi.org/10.1182/blood-2025-455

Published: 2025

Journal Articles

First-in-human evaluation of IL2RG blockade in patients with severe aplastic anemia that is refractory to or relapsed on immunosuppressive therapy

Blood (2025) 146 (Supplement 1): 27.

https://doi.org/10.1182/blood-2025-27

Published: 2025

Journal Articles

Final results of a phase I/II trial of palbociclib and CPX-351 in patients with Acute Myeloid Leukemia

Chana Peysin, Aziz Nazha, Wei Wei, Aaron Gerds, Xiaoying Chen, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Eric Parsons, Jenna Thomas, Bhumika Patel, Jaroslaw Maciejewski, Mikkael Sekeres, Babal Jha, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3420.

https://doi.org/10.1182/blood-2025-3420

Published: 2025

Journal Articles

Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort

Blood (2025) 146 (Supplement 1): 3396.

https://doi.org/10.1182/blood-2025-3396

Published: 2025

Journal Articles

A phase II study of eltrombopag in patients with low-risk MDS and CMML harboring TET2 mutations

Abhay Singh, Akriti Jain, Sophia Balderman, Sujata Patil, Anjali Advani, Moaath Mustafa Ali, John Molina, Taylor Lucas, Tracy Cinalli, Ramandeep Mann, Lucy McCahon, Sudipto Mukherjee, Aaron Gerds, Yogen Saunthararajah, Jaroslaw Maciejewski, Hetty Carraway, Babal Jha, Alex Adjei

Blood (2025) 146 (Supplement 1): 2096.

https://doi.org/10.1182/blood-2025-2096

Published: 2025

Journal Articles

Risk of second primary malignancies and leukemic transformation in patients with Philadelphia chromosome-negative myeloproliferative neoplasms: A population-level US retrospective cohort study

Debolina Pramanik, Yanwen Chen, Shramana Sarkar, Aaron Gerds, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3790.

https://doi.org/10.1182/blood-2025-3790

Published: 2025

Journal Articles

Survival and risk of second primary malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A retrospective US population-level analysis

Debolina Pramanik, Yanwen Chen, Shramana Sarkar, Ishan Gupta, Aaron Gerds, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3772.

https://doi.org/10.1182/blood-2025-3772

Published: 2025

Journal Articles

Longitudinal analysis of first and subsequent-line tyrosine kinase inhibitor use in chronic myeloid leukemia: A 16-year single-center experience

Moaath Mustafa Ali, Emily Zabor, Kamilla Abdurakhmanov, Hadil Zureigat, Ahmed Nabil, Muaz Alsabbagh Alchirazi, Aastha Dhakal, Ali Mushtaq, Naveen Rehman, Bryan Berube, Akriti Jain, John Molina, Sophia Balderman, Abhay Singh, Aaron Gerds, Anjali Advani, Hetty Carraway, Matt Kalaycio, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 2012.

https://doi.org/10.1182/blood-2025-2012

Published: 2025

Journal Articles

A Phase 1B/2A study of weekly decitabine and venetoclax treatment as maintenance therapy in high-risk myeloid malignancy patients post allogeneic stem cell transplantation

Sophia Balderman, James Ignatz-Hoover, Claudio Brunstein, Yogen Saunthararajah, Ben Tomlinson

Blood (2025) 146 (Supplement 1): 2510.

https://doi.org/10.1182/blood-2025-2510

Published: 2025

Journal Articles

The Impact of the number of cytogenetic abnormalities on clinical outcomes in Acute Myeloid Leukemia with complex karyotype

Blood (2025) 146 (Supplement 1): 1628.

https://doi.org/10.1182/blood-2025-1628

Published: 2025

Journal Articles

Association of socioeconomic indicators with survival in chronic myeloid leukemia: A retrospective analysis

Blood (2025) 146 (Supplement 1): 4636.

https://doi.org/10.1182/blood-2025-4636

Published: 2025

Journal Articles

Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study

Omer Ashruf, Henyah Dardir, Ankit Patel, Emily Moncher, Nandhini Ravichandran, David Kaelber, Sophia Balderman, Anjali Advani, John Molina, Moaath Mustafa Ali, Aaron Gerds, Hetty Carraway, Faiz Anwer, Abhay Singh, Sudipto Mukherjee, Larry Cripe, Akriti Jain

Blood (2025) 146 (Supplement 1): 4627.

https://doi.org/10.1182/blood-2025-4627

Published: 2025

Journal Articles

Impact of cohesin complex gene mutations on clinical outcomes in Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 4626.

https://doi.org/10.1182/blood-2025-4626

Published: 2025

Journal Articles

TP53 and PPM1D mutations in AML: Distinct frequencies, shared pathway, and adverse prognostic trends

Blood (2025) 146 (Supplement 1): 5168.

https://doi.org/10.1182/blood-2025-5168

Published: 2025

Journal Articles

Outcomes of Accelerated and Blast Phase Chronic Myeloid Leukemia at a Tertiary Center

Ahmed N Mohamed, Hadil Zureigat, Muaz Alsabbagh Alchirazi, Aastha Dhakal, Ali Mushtaq, Naveen Rehman, Bryan Berube, Sneha Govande, Emily C. Zabor, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Anjali S. Advani, Hetty E. Carraway, Matt Kalaycio, Sudipto Mukherjee, Moaath K. Mustafa Ali

Blood (2024) 144 (Supplement 1): 6610.

https://doi.org/10.1182/blood-2024-210152

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Risk of cardiovascular disease-related mortality in hematologic malignancy patients: A population-level US retrospective cohort study, 1975-2022

Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort

Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis

Prognostic impact of mutations in the DNA methylation pathway on clinical outcomes in acute myeloid leukemia: A retrospective cohort study

Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates

The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission

First-in-human evaluation of IL2RG blockade in patients with severe aplastic anemia that is refractory to or relapsed on immunosuppressive therapy

Final results of a phase I/II trial of palbociclib and CPX-351 in patients with Acute Myeloid Leukemia

Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort

A phase II study of eltrombopag in patients with low-risk MDS and CMML harboring TET2 mutations

Risk of second primary malignancies and leukemic transformation in patients with Philadelphia chromosome-negative myeloproliferative neoplasms: A population-level US retrospective cohort study

Survival and risk of second primary malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A retrospective US population-level analysis

Longitudinal analysis of first and subsequent-line tyrosine kinase inhibitor use in chronic myeloid leukemia: A 16-year single-center experience

A Phase 1B/2A study of weekly decitabine and venetoclax treatment as maintenance therapy in high-risk myeloid malignancy patients post allogeneic stem cell transplantation

The Impact of the number of cytogenetic abnormalities on clinical outcomes in Acute Myeloid Leukemia with complex karyotype

Association of socioeconomic indicators with survival in chronic myeloid leukemia: A retrospective analysis

Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study

Impact of cohesin complex gene mutations on clinical outcomes in Acute Myeloid Leukemia

TP53 and PPM1D mutations in AML: Distinct frequencies, shared pathway, and adverse prognostic trends

Outcomes of Accelerated and Blast Phase Chronic Myeloid Leukemia at a Tertiary Center

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only